help button home button Endocrine Society JCEM JCEM Call for Nominations for EIC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Löfgren, P.
Right arrow Articles by Arner, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Löfgren, P.
Right arrow Articles by Arner, P.
The Journal of Clinical Endocrinology & Metabolism Vol. 87, No. 2 764-771
Copyright © 2002 by The Endocrine Society


Other Original Articles

Major Gender Differences in the Lipolytic Capacity of Abdominal Subcutaneous Fat Cells in Obesity Observed before and after Long-Term Weight Reduction

Patrik Löfgren, Johan Hoffstedt, Mikael Rydén, Anders Thörne, Cecilia Holm, Hans Wahrenberg and Peter Arner

Karolinska Institute, Clinical Research Center and Departments of Medicine (P.L., J.H., M.R., H.W., P.A.) and Surgery (A.T.), Huddinge University Hospital, S-141 86 Stockholm, Sweden; and Department of Cell and Molecular Biology, Lund University (C.H.), S-22100 Lund, Sweden

Address all correspondence and requests for reprints to: Peter Arner, M.D., Karolinska Institute, CME M61, MK Division, Huddinge University Hospital, S-141 86 Stockholm, Sweden. E-mail: peter.arner{at}medhs.ki.se

Abstract

The influence of obesity on the lipolytic capacity of isolated sc fat cells was studied prospectively in 13 women and 10 men, all obese, but otherwise healthy, before and 2 and 3 yr after weight reduction by bariatric surgery. Nonobese subjects (25 women and 17 men) without a family history of obesity served as the control group. Lipolytic capacity was determined after stimulation at different steps of the lipolytic cascade with noradrenaline, isoprenaline, forskolin, and (Bu)2AMP. Bariatric surgery was followed by a marked and similar reduction of body mass index and fat cell volume (~40%) in both genders. Before weight loss, lipolytic capacity per cell was elevated in obese women and decreased to normal levels after weight reduction at 2 and 3 yr. However, lipolytic capacity per fat cell surface area was not changed in obese women. In obese men, lipolytic capacity per cell was almost the same as in lean men and was not influenced by weight reduction. Lipolytic capacity was related to fat cell size in women (P = 0.0008; r = 0.58), but not in men (P = 0.67; r = 0.086). The protein content of hormone-sensitive lipase, which determines lipolytic capacity, was significantly lower in obese men and women and increased slightly after weight reduction in men only. Thus, in women, but not in men, the adipocyte lipolytic capacity is influenced by obesity and weight reduction, probably due to changes in fat cell size. These gender differences are not related to the amount of hormone-sensitive lipase protein in adipocytes.




This article has been cited by other articles:


Home page
DiabetesHome page
J. W.E. Jocken, C. Roepstorff, G. H. Goossens, P. van der Baan, M. van Baak, W. H.M. Saris, B. Kiens, and E. E. Blaak
Hormone-Sensitive Lipase Serine Phosphorylation and Glycerol Exchange Across Skeletal Muscle in Lean and Obese Subjects: Effect of {beta}-Adrenergic Stimulation
Diabetes, July 1, 2008; 57(7): 1834 - 1841.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
T. Agustsson, M. Ryden, J. Hoffstedt, V. van Harmelen, A. Dicker, J. Laurencikiene, B. Isaksson, J. Permert, and P. Arner
Mechanism of Increased Lipolysis in Cancer Cachexia
Cancer Res., June 1, 2007; 67(11): 5531 - 5537.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
J. W. E. Jocken, D. Langin, E. Smit, W. H. M. Saris, C. Valle, G. B. Hul, C. Holm, P. Arner, and E. E. Blaak
Adipose Triglyceride Lipase and Hormone-Sensitive Lipase Protein Expression Is Decreased in the Obese Insulin-Resistant State
J. Clin. Endocrinol. Metab., June 1, 2007; 92(6): 2292 - 2299.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
E. A. Nordstrom, M. Ryden, E. C. Backlund, I. Dahlman, M. Kaaman, L. Blomqvist, B. Cannon, J. Nedergaard, and P. Arner
A Human-Specific Role of Cell Death-Inducing DFFA (DNA Fragmentation Factor-{alpha})-Like Effector A (CIDEA) in Adipocyte Lipolysis and Obesity
Diabetes, June 1, 2005; 54(6): 1726 - 1734.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2002 by The Endocrine Society